Successful treatment of pituitary carcinoma with concurrent radiation, temozolomide, and bevacizumab after resection.
Journal of Clinical Neuroscience(2017)
Abstract
•Temozolomide, bevacizumab, and radiation can be effective for pituitary carcinoma.•Complete remission in pituitary carcinoma can be achieved by combined modality.•Using bevacizumab in the first line therapy may be warranted in pituitary carcinoma.•Combining temozolomide and bevacizumab with radiation was safe in our case.
MoreTranslated text
Key words
Pituitary carcinoma,Atypical pituitary adenoma,Temozolomide,Bevacizumab
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined